Skip to main content
HOLISTA COLLTECH LIMITED logo

HOLISTA COLLTECH LIMITED — Investor Relations & Filings

Ticker · HCT ISIN · AU000000HCT4 ASX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2020-04-15 Regulatory Filings
Country AU Australia
Listing ASX HCT

About HOLISTA COLLTECH LIMITED

https://www.holistaco.com

Holista CollTech Limited is a research-driven company focused on the development and commercialization of natural health products and ingredients. The company specializes in three primary areas: ovine collagen, food-grade ingredients, and infection control solutions. Its proprietary collagen extraction technology produces high-quality, disease-free ovine collagen for the cosmetic and medical industries. In the food sector, the company develops low-glycemic index (GI) formulations for staple foods like bread, noodles, and pasta to address global health concerns such as diabetes and obesity. Additionally, Holista CollTech offers natural sanitization products based on plant-derived active ingredients. The company aims to provide scientifically validated solutions that enhance wellness and food quality through sustainable and natural processes.

Recent filings

Filing Released Lang Actions
Trading Halt 3 pages 148.5KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Holista CollTech Limited regarding a trading halt request. It states that the securities will be placed in trading halt pending an announcement about test results related to COVID-19 efficacy. The document is short (3482 characters) and is an announcement of a trading halt, not a financial report or detailed disclosure. It does not contain financial data, management discussion, or regulatory filings beyond the trading halt notice. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-04-15 English
US Distributor increases order of Natshield to $3.8M 2 pages 63.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 9 April 2020 from Holista CollTech Limited regarding increased orders of their product NatShield™ by their U.S. distributor. It provides details about the order volume, expected delivery dates, and supply chain arrangements. There is no financial statement, quarterly or annual report data, or detailed financial analysis. The document is a corporate announcement about sales and distribution updates, which fits best under Capital/Financing Update (CAP) as it relates to business activity impacting revenue but is not a formal earnings release or financial report. The document length is 4317 characters, which is short and typical for an announcement rather than a full report. Therefore, the classification is CAP with high confidence.
2020-04-08 English
Change of Director's Interest Notice 2 pages 85.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including the number of shares held before and after the change, nature of the change, and related contract interests. This type of document is a formal notification of personal share transactions by a company director, which aligns with the definition of 'Director's Dealing' filings. The document is not a full financial report, earnings release, or management report, but a specific insider trading disclosure. Therefore, the correct classification is DIRS (Director's Dealing). The document length and content fully support this classification with high confidence.
2020-04-08 English
Achievement of Performance Rights Milestones 4 pages 84.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 8 April 2020 from Holista CollTech Limited regarding the achievement of performance rights milestones. It details the satisfaction of specific performance conditions related to product commercialization and patent transfers, and the subsequent approval by the board for conversion of performance rights into shares. The document references prior ASX announcements and includes details about the share allotment to be lodged with ASX in an Appendix 2A. There are no financial statements or comprehensive financial data presented, nor is this a report or presentation. The content is an official announcement about milestone achievement and share allotment related to performance rights, which fits best under Capital/Financing Update (CAP) as it relates to equity issuance and capital structure changes. The document length is sufficient and contains substantive information, not merely a notice or certification, so it is not RPA or RNS. Therefore, the classification is CAP with high confidence.
2020-04-07 English
Appendix 2A 16 pages 192.2KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, and the circumstances of the issue. This form is a regulatory announcement related to capital markets activity, specifically the issuance and quotation of new securities. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement or a certification. The document fits the category of Capital/Financing Update (CAP) because it provides updates on the company's capital structure changes and securities issuance.
2020-04-07 English
Binding agreement with Skin Elements to launch sanitiser 4 pages 727.9KB
Regulatory Filings Classification · 95% confidence The document is a joint ASX announcement dated 2 April 2020, detailing a binding agreement between Skin Elements Limited and Holista Colltech Limited to launch a new natural hand sanitiser product. The content focuses on the collaboration, product details, production capacity, distribution plans, and company backgrounds. There are no financial statements, regulatory certifications, voting results, or management changes discussed. The document is an announcement of a business collaboration and product launch rather than a financial report, regulatory filing, or management report. Therefore, it fits best under the category of a general regulatory announcement or compliance-related announcement that does not fit other specific categories. Given the nature and content, the most appropriate classification is Regulatory Filings (RNS).
2020-04-02 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.